Journal of Jilin University(Medicine Edition) ›› 2024, Vol. 50 ›› Issue (6): 1691-1702.doi: 10.13481/j.1671-587X.20240623
• Research in clinical medicine • Previous Articles Next Articles
Yanyan LU1,2,Xiangbo XU1,3,Yamei WU2,Yuqi LIU1,Han WANG1,Lijuan YANG1,Zhenjiang WANG1,Zishen XIAO1,Yanbo LIU1(
)
Received:2024-01-08
Online:2024-11-28
Published:2024-12-10
Contact:
Yanbo LIU
E-mail:liuyanbobeihua@163.com
CLC Number:
Yanyan LU,Xiangbo XU,Yamei WU,Yuqi LIU,Han WANG,Lijuan YANG,Zhenjiang WANG,Zishen XIAO,Yanbo LIU. Eosinophil infiltration in cervical lesion and cervical cancer tissues and their clinical significances[J].Journal of Jilin University(Medicine Edition), 2024, 50(6): 1691-1702.
Tab.1
General characteristics of patients in various groups"
| Group | n | Mean age | Surgical history | Children | Menopause | Family history | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| + | - | 0 | 1 | >1 | + | - | History of cancer in immediate family members | No history of cancer in immediate family members | |||
| Normal | 30 | 56.0 | 12 | 34 | 4 | 31 | 11 | 27 | 19 | 13 | 33 |
| Chronic cervicitis | 30 | 42.2 | 5 | 25 | 1 | 22 | 7 | 6 | 24 | 7 | 23 |
| CIN stage Ⅰ | 50 | 43.5 | 3 | 47 | 0 | 8 | 42 | 12 | 38 | 5 | 45 |
| CIN stage Ⅱ | 50 | 40.2 | 12 | 38 | 5 | 40 | 5 | 9 | 41 | 6 | 44 |
| CIN stage Ⅲ | 50 | 40.9 | 3 | 47 | 0 | 40 | 10 | 4 | 46 | 1 | 49 |
| Cervical cancer | 46 | 48.0 | 6 | 24 | 1 | 25 | 4 | 3 | 27 | 6 | 24 |
Tab.2
Pathological features of cervical cancer tissue"
| Pathological feature | Clinical parameter | Number of cases |
|---|---|---|
Size of primary tumor (mm) | 0-5 | 20 |
| 6-10 | 22 | |
| >10 | 4 | |
Depth of infiltration(mm) | <3 | 15 |
| 3-5 | 23 | |
| 6-20 | 8 | |
| ≥21 | 0 | |
Grade of differentiation | Highly differentiated | 14 |
| Moderately differentiated | 20 | |
| Poorly differentiated | 12 | |
Tumor grade | Grade Ⅰ | 29 |
| Grade Ⅱ | 13 | |
| Grade Ⅲ | 4 | |
| Vascular invasion | - | 15 |
| Accumulative glands | - | 39 |
| Lymphatic metastasis | 0 | 28 |
| ≥1 | 18 | |
| Number of eosinophil infiltration (number·mm-2) | <50 | 20 |
| ≥50 | 26 |
| 1 | BRAY F, LAVERSANNE M, WEIDERPASS E, et al. The ever-increasing importance of cancer as a leading cause of premature death worldwide[J]. Cancer, 2021, 127(16): 3029-3030. |
| 2 | SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. |
| 3 | 蔡会龙, 原伟光. 全球及我国宫颈癌流行现状及防治策略[J]. 临床肿瘤学杂志, 2023, 28(1): 90-93. |
| 4 | ZHENG R S, ZHANG S W, ZENG H M, et al. Cancer incidence and mortality in China, 2016[J]. J Natl Cancer Cent, 2022, 2(1): 1-9. |
| 5 | KPOGHOMOU M A, GENEAU M, MENARD J, et al. Assessment of an onco-sexology support and follow-up program in cervical or vaginal cancer patients undergoing brachytherapy[J]. Support Care Cancer, 2021, 29(8): 4311-4318. |
| 6 | 何朝奎. 肿瘤免疫治疗中嗜酸性粒细胞作用的研究进展[J]. 中国肿瘤生物治疗杂志, 2023, 30(2): 178-182. |
| 7 | GRISARU-TAL S, ROTHENBERG M E, MUNITZ A. Eosinophil-lymphocyte interactions in the tumor microenvironment and cancer immunotherapy[J]. Nat Immunol, 2022, 23(9): 1309-1316. |
| 8 | REICHMAN H, KARO-ATAR D, MUNITZ A. Emerging roles for eosinophils in the tumor microenvironment[J]. Trends Cancer, 2016, 2(11): 664-675. |
| 9 | DAVIS B P, ROTHENBERG M E. Eosinophils and cancer[J]. Cancer Immunol Res, 2014, 2(1): 1-8. |
| 10 | 王思羽, 王宽松. 嗜酸性粒细胞在肿瘤免疫微环境中的作用研究进展[J]. 中国普通外科杂志, 2022, 31(5): 675-687. |
| 11 | 肖梓屾, 刁书腾, 张莉爽, 等. IL-17A对前列腺癌细胞迁移的促进作用及其机制[J]. 吉林大学学报(医学版), 2020, 46(6): 1194-1201. |
| 12 | GHAFFARI S, REZAEI N. Eosinophils in the tumor microenvironment: implications for cancer immunotherapy[J]. J Transl Med, 2023, 21(1): 551. |
| 13 | SIMSON L, ELLYARD J I, DENT L A, et al. Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor immune surveillance[J]. J Immunol, 2007, 178(7): 4222-4229. |
| 14 | SOSMAN J A, BARTEMES K, OFFORD K P, et al. Evidence for eosinophil activation in cancer patients receiving recombinant interleukin-4: effects of interleukin-4 alone and following interleukin-2 administration[J]. Clin Cancer Res, 1995, 1(8): 805-812. |
| 15 | HULAND E, HULAND H. Tumor-associated eosinophilia in interleukin-2-treated patients: evidence of toxic eosinophil degranulation on bladder cancer cells[J]. J Cancer Res Clin Oncol, 1992, 118(6): 463-467. |
| 16 | BENATAR T, CAO M Y, LEE Y, et al. IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo [J]. Cancer Immunol Immunother, 2010, 59(6): 805-817. |
| 17 | GRISARU-TAL S, ITAN M, KLION A D, et al. A new dawn for eosinophils in the tumour microenvironment[J]. Nat Rev Cancer, 2020, 20(10): 594-607. |
| 18 | VESTERINEN E, PUKKALA E, TIMONEN T, et al. Cancer incidence among 78 000 asthmatic patients[J]. Int J Epidemiol, 1993, 22(6): 976-982. |
| 19 | ZHU J, WANG H, GAO M J, et al. Prognostic values of lymphocyte and eosinophil counts in resectable cervical squamous cell carcinoma[J]. Future Oncol, 2019, 15(30): 3467-3481. |
| 20 | ZHU J, WANG H, GAO M J, et al. Prognostic values of lymphocyte and eosinophil counts in resectable cervical squamous cell carcinoma[J]. Future Oncol, 2019, 15(30): 3467-3481. |
| 21 | PESCE S, THOREN F B, CANTONI C, et al. The innate immune cross talk between NK cells and eosinophils is regulated by the interaction of natural cytotoxicity receptors with eosinophil surface ligands[J]. Front Immunol, 2017, 8: 510. |
| 22 | BANDEIRA-MELO C, BOZZA P T, WELLER P F. The cellular biology of eosinophil eicosanoid formation and function[J]. J Allergy Clin Immunol, 2002, 109(3): 393-400. |
| 23 | NISSIM BEN EFRAIM A H, LEVI-SCHAFFER F. Roles of eosinophils in the modulation of angiogenesis[J]. Chem Immunol Allergy, 2014, 99: 138-154. |
| 24 | YOUSEFI S, HEMMANN S, WEBER M, et al. IL-8 is expressed by human peripheral blood eosinophils. Evidence for increased secretion in asthma[J]. J Immunol, 1995, 154(10): 5481-5490. |
| 25 | KLEFFEL S, POSCH C, BARTHEL S R, et al. Melanoma cell-intrinsic PD-1 receptor functions promote tumor growth[J]. Cell, 2015, 162(6): 1242-1256. |
| 26 | MATTEI F, ANDREONE S, MARONE G, et al. Eosinophils in the tumor microenvironment[J]. Adv Exp Med Biol, 2020, 1273: 1-28. |
| 27 | LEGRAND F, DRISS V, DELBEKE M, et al. Human eosinophils exert TNF-α and granzyme A-mediated tumoricidal activity toward colon carcinoma cells[J]. J Immunol, 2010, 185(12): 7443-7451. |
| 28 | QIU Y F, NGUYEN K D, ODEGAARD J I, et al. Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat[J]. Cell, 2014, 157(6): 1292-1308. |
| 29 | 李 双, 李明珠, 丛 青, 等. 人乳头瘤病毒疫苗临床应用中国专家共识[J]. 中国妇产科临床杂志, 2021, 22(2): 225-234. |
| 30 | 薛剑侠, 王玉兰, 李晓旭, 等. 人乳头瘤病毒在宫颈癌发病机制中的研究进展[J]. 中国药物与临床, 2017, 17(4): 542-543. |
| 31 | 崔湘杰, 史 荔, 陶玉芬. HPV E2、E5致癌机制及相关疫苗研究进展[J]. 中华疾病控制杂志, 2024, 28(1): 96-100. |
| 32 | 王佳森, 张 妍, 付晓雪, 等. 宫颈癌免疫学发病机制研究进展[J]. 国际妇产科学杂志, 2022, 49(2): 207-211. |
| 33 | 贾荣霞, 周 旭, 石贽堃, 等. 宫颈上皮内瘤变Ⅰ级患者病变进展危险因素分析[J]. 吉林大学学报(医学版), 2022, 48(6): 1528-1534. |
| 34 | RIMINI M, FRANCO P, BERTOLINI F, et al. The prognostic role of baseline eosinophils in HPV-related cancers: a multi-institutional analysis of anal SCC and OPC patients treated with radical CT-RT[J]. J Gastrointest Cancer, 2023, 54(2): 662-671. |
| 35 | REGAUER S, REICH O. The histologic and molecular spectrum of highly differentiated HPV-independent cervical intraepithelial neoplasia[J]. Am J Surg Pathol, 2023, 47(8): 942-949. |
| 36 | MARKS M A, VISCIDI R P, CHANG K, et al. Differences in the concentration and correlation of cervical immune markers among HPV positive and negative perimenopausal women[J]. Cytokine, 2011, 56(3): 798-803. |
| [1] | Xiaohui LIANG,Wenna LIU,Jianbo ZHAO. Bioinformatic analysis on PAQR3 expression in hepatocellular carcinoma and its correlations with T lymphocyte infiltration, immune checkpoint genes, and patient survival [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 781-790. |
| [2] | Xiaoshuang HE,Lina XU,Mei CUI,Wenyan XIN. Inhibitory effect of BMSCs over-expressing FOXO1 on pulmonary eosinophil infiltration and airway remodeling in asthmatic mice and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2023, 49(5): 1192-1201. |
| [3] | Rongxia JIA,Xu ZHOU,Zhikun SHI,Meijing BAO,Guanqun WANG,Yuqing CHU,Yang LIN. Analysis on risk factors for disease progression of patients with cervical intraepithelial neoplasia Ⅰ [J]. Journal of Jilin University(Medicine Edition), 2022, 48(6): 1528-1534. |
| [4] | QIANG Xin, HUO Wenyan, YANG Can, FAN Yanan, SHI Caiyun, BAI Haihua. Expressions of p16INK4a protein in cervical lesion tissues of Mongolian patients and their significances [J]. Journal of Jilin University Medicine Edition, 2017, 43(02): 353-355. |
| [5] | HAN Dong,DONG Xue-lian,QIU Zhi-dong. Antiasthmatic effect of 1-methylhydantoin on rat asthma model and its mechanism [J]. Journal of Jilin University Medicine Edition, 2014, 40(03): 543-548. |
| [6] | GAO Kun,HU Mei-qin,QI Hong-gang,WENG Guo-bin,GAO Wen-bo,YAO Xu-ping. Protective effect of salidroside on renal ischemia-reperfusion injury in rats [J]. J4, 2012, 38(4): 687-691. |
| [7] | LI Dan|YUAN Hai-bo|PENG Li-ping|HUA Shu-cheng. Classification of |bronchial asthma based on pathological features and their responses to corticosteroid [J]. J4, 2010, 36(6): 1130-1133. |
| [8] | XIE Tie-nan,FENG Li-hua,YU Xiao-wei. Effects of loop electrosurgical excision procedure on diagnosisand treatment for cervical intraepithelial neoplasia [J]. J4, 2004, 30(3): 462-464. |
|